Xiong Y, Uys JD, Tew KD, et al. S-glutathionylation: from molecular mechanisms to health outcomes. Antioxid Redox Signal 2011; 15: 233-270.
Peltoniemi MJ, Rytila PH, Harju TH, et al. Modulation of glutaredoxin in the lung and sputum of cigarette smokers and chronic obstructive pulmonary disease. Respir Res 2006; 7: 133.
Reynaert NL, Wouters EF, Janssen-Heininger YM. Modulation of glutaredoxin-1 expression in a mouse model of allergic airway disease. Am J Respir Cell Mol Biol 2007; 36: 147-151.
Brightling CE. Sputum induction in asthma: A research technique or a clinical toolChest 2006; 129: 503-504.
Nagai K, Betsuyaku T, Konno S, et al. Diversity of protein carbonylation in allergic airway inflammation. Free Radic Res 2008; 42: 921-929.
Peltoniemi M, Kaarteenaho-Wiik R, Saily M, et al. Expression of glutaredoxin is highly cell specific in human lung and is decreased by transforming growth factor-b in vitro and in interstitial lung diseases in vivo. Hum Pathol 2004; 35: 1000-1007.
Lundberg M, Fernandes AP, Kumar S, et al. Cellular and plasma levels of human glutaredoxin 1 and 2 detected by sensitive ELISA systems. Biochem Biophys Res Commun 2004; 319: 801-809.
Aesif SW, Anathy V, Guala AS, et al. Ablation of glutaredoxin-1 attenuates lipopolysaccharide-induced lung inflammation and alveolar macrophage activation. Am J Respir CellMol Biol 2011; 44: 491-499.
